SCHEMBL6162256

SCHEMBL6162256

CC(C)Cc1nn(-c2ccccc2)c2c1C(=O)CC(C)(C)C2

nearest known ligand 0.50

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
OPRM1 P35372 10/20 0.50
ALDH1A1 P00352 5/20 0.47
KMT2A Q03164 3/20 0.47
NPSR1 Q6W5P4 2/20 0.47
LMNA P02545 4/20 0.46
TSHR P16473 2/20 0.46
HSP90AB1 P08238 1/20 0.46
SRC P12931 1/20 0.43
HTT P42858 2/20 0.43
HSD17B10 Q99714 2/20 0.43
RAB9A P51151 1/20 0.43
MEN1 O00255 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
TP53 P04637 1/20 0.42
ALOX15 P16050 1/20 0.42
MAPK1 P28482 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7479730 0.88 OPRM1 (0.54) OPRM1ALDH1A1NPSR1LMNAHSP90AB1
SCHEMBL6769536 0.88 OPRM1 (0.51) OPRM1ALDH1A1NPSR1LMNAHSP90AB1
SCHEMBL6770491 0.88 OPRM1 (0.51) OPRM1ALDH1A1KMT2ANPSR1LMNA
SCHEMBL6164280 0.87 OPRM1 (0.45) OPRM1ALDH1A1KMT2ANPSR1LMNA
SCHEMBL6769486 0.86 OPRM1 (0.55) OPRM1ALDH1A1NPSR1LMNAHSP90AB1
SCHEMBL1220615 0.84 HSP90AA1 (0.53) OPRM1ALDH1A1KMT2ANPSR1HSP90AB1
SCHEMBL6163724 0.84 ALDH1A1 (0.65) OPRM1ALDH1A1KMT2ANPSR1LMNA
SCHEMBL6164703 0.84 OPRM1 (0.45) OPRM1ALDH1A1KMT2ANPSR1LMNA
SCHEMBL6168169 0.81 OPRM1 (0.53) OPRM1ALDH1A1KMT2ANPSR1LMNA
SCHEMBL6165127 0.80 ALDH1A1 (0.43) OPRM1ALDH1A1KMT2ALMNATSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1177185-B1 4, 5, 6, 7-TETRAHYDROINDAZOLE DERIVATIVES AS ANTITUMOR AGENTS PHARMACIA ITALIA SPA (IT) 2005-04-20 EP disclosed
US-6716856-B1 CELL PROLIFERATIVE DISORDERS OR ALZHEIMER'S DISEASE; REDUCED TOXICITY; CDK/CYCLIN KINASE INHIBITORY ACTIVITY PHARMACIA & TUBJOHN SPA (IT) 2004-04-06 US disclosed